- Akari will host an analyst and investor symposium on Saturday, Dec 3 - NEW YORK and LONDON, November 3rd, 2016 Akari Therapeutics (NASDAQ: AKTX), an …

[Read more...] about Akari Therapeutics to Present Abstract on Potential Once Weekly PAS-Coversin at the 58th Annual Meeting of the American Society of Hematology

NEW YORK and LONDON, October 14th, 2016 Akari Therapeutics (NASDAQ: AKTX), an emerging growth, clinical-stage biopharmaceutical company, announced today the …

[Read more...] about Akari Therapeutics Appoints New Members to its Board of Directors